Canonical Question
Amiodarone Pharmacology
Master answer
Side Effects of Amiodarone:
Side effects reflect long elimination half-life and significant accumulation in tissues. Side affects increase when maintenance doses are above 400mg daily.
- Respiratory
- Most serious is pneumonitis. Risk is 5-10% at 3 years with a mortality of 10% long term.
- May be due to increased oxygen free radicals and risk increased by high FiO2
- 2 phenotypes- slow insidious and acute onset
- May be reversible if treatment stopped early
- Cardiac
- Prolonged QTc with Torsade’s
- Proarrhythmic (ventricular tachyarrhythmia)
- Bradycardias resistant to atropine
- Peripheral vasodilation leading to hypotension with decreased responsiveness to adrenergic stimuli
- Neurological
- Peripheral neuropathy, tremor, sleep disturbance
- Myopathy
- Endocrine
- Both hyperthyroidism and hypothyroidism may occur (usually reversible)- 2-4% of patients
- Prevents peripheral conversion of T4 to T3 (detected by increased plasma [TSH])
- 37% of weight of Amiodarone is iodine, which may precipitate hyperthyroidism
- Pre-existing thyroid disease increases risk
- GIT
- Hepatitic dysfunction, LFT derangement and cirrhosis has been observed
- Metallic taste during loading
- Ophthalmic
- Corneal microdeposits but visual impairment less likely
- Optic neuropathy (insidious onset, bilateral). Often reversible if discontinued
- Dermatological
- Photosensitivity
- Slate gray pallor of the face, continues after drug discontinuation
- Pregnancy and lactation
- Avoid in from 3 months pre-pregnancy to after breast feeding has finished
- May cause hypothyroidism and bradycardia in the fetus. Foetal hypothyroidism may lead to impairment of myelination
- Contraindicated in porphyria
- Miscellaneous
- IV preparation is irritant and should be administered through a central vessel
Exam appearances
| Exam | Exact wording | Relationship | Success |
|---|---|---|---|
| 2014B Q13 | Outline the pharmacology of amiodarone. | historical_member | — |
| 2024A Q19 | Describe the pharmacology of amiodarone using the following headings: (i) Indications for use (5% of marks) (ii) Dose (10% of marks) (iii) Mechanism of Action (20% of marks) (iv) Pharmacodynamics including adverse effects (25% of marks) (v) Pharmacokinetics (25% of marks) (vi) Drug Interactions (15% of marks). | historical_member | — |
| 2008B Q05 | Outline the pharmacology of amiodarone. | historical_member | — |
| 2016A Q11 | Provide a detailed account of the side effects of Amiodarone. | historical_member | — |
| 2021B Q11 | Provide a detailed account of the side-effects of amiodarone. | historical_member | — |